摘要
目的:系统评价降钙素原(PCT)指导卒中相关性肺炎(SAP)的抗菌药物应用。方法:应用Meta分析方法,对检索并入选的13篇随机对照试验(RCT)进行综合分析。结果:共纳入1 299例患者,Meta分析结果显示:与传统以抗菌药物治疗指南组相比,PCT组能够缩短抗菌药物使用疗程[MD=-3.15,95%CI(-3.68,-2.63),P<0.000 01],缩短住院时间[MD=-2.91,95%CI(-4.67,-1.15),P<0.000 01],而临床有效率[OR=1.44,95%CI(0.91,2.29),P=0.12]及病死率[OR=0.80,95%CI(0.53,1.20),P=0.28]无显著差异。结论:PCT指导卒中相关性肺炎的抗菌药物治疗,能缩短抗菌药物使用疗程及住院时间,且安全、有效、可行。
Objective: To systematically evaluate the effectiveness and safety of procalcitonin(PCT)-guided therapy in comparison with standard stroke guidelines in patients with suspected or confirmed Stroke associated pneumonia(SAP). Methods: Thirteen randomized controlled trials(1299 patients) were included for statistical analysis using Cochrane Rev Man 5.1 software. Results: PCT-guided therapy was associated with a significant reduction in duration of antibiotics [MD=-3.15, 95% CI(-3.68,-2.63), P0.000 01] and length of hospital stay [MD =-2.91, 95% CI(-4.67,-1.15), P 0.000 01], but the clinical efficiency [OR =1.44, 95% CI(0.91, 2.29), P =0.12] and the mortality [OR =0.80, 95% CI(0.53, 1.20), P =0.28] were not significantly different. Conclusion: The implementation of a procalcitonin-based algorithm may reduce antibiotic exposure and length of antibiotics in patients with stroke associated pneumonia.
出处
《临床药物治疗杂志》
2016年第6期34-40,共7页
Clinical Medication Journal
关键词
降钙素原
卒中相关性肺炎
随机对照试验
META分析
procalcitonin
stroke associated pneumonia
randomized controlled trials
meta-analysis